Example: Heart Attack

Clinical Trials Sponsored by Azienda Ospedaliera Niguarda Ca Granda

Total 10 results

    • NCT03498664
      Unknown status
      EMR-C VS EMR-S in Colonic Lateral Spreading Tumors Treatment (LST)
      Conditions: Endoscopic Mucosal Resection
    • NCT01158846
      Unknown status
      Bivalirudin/Prasugrel Versus Abciximab/Clopidogrel in Patients Presenting With STEMI
      Conditions: ST-Elevation Myocardial Infarction; Primary Percutaneous Coronary Intervention
    • NCT04434417
      Recruiting
      Validation of an Immunochromatographic Assay for IgG/IgM Antibodies to 2019- nCoV
      Conditions: COVID
    • NCT03359538
      Active, not recruiting
      Rapamycin Treatment for ALS
      Conditions: Amyotrophic Lateral Sclerosis
    • NCT03858088
      Completed
      Early Allograft Failure Simplified Estimation (EASE) in Liver Transplantation
      Conditions: Liver Transplant Failure
    • NCT01360346
      Unknown status
      Enteral Versus Intravenous Sedation in Critically Ill High-risk ICU Patients
      Conditions: Critical Illness; Mechanical Ventilation Complication
    • NCT04031872
      Not yet recruiting
      LY3200882 and Capecitabine in Advanced Resistant TGF-beta Activated Colorectal Cancer (EORTC1615)
      Conditions: Colorectal Cancer Metastatic
    • NCT03482362
      Unknown status
      Vinorelbine in Advanced BRAF-like Colon Cancer
      Conditions: Colon Cancer
    • NCT03470350
      Withdrawn
      Galunisertib and Capecitabine in Advanced Resistant TGF-beta Activated Colorectal Cancer
      Conditions: Colorectal Cancer Metastatic
    • NCT01411579
      Completed
      Use of DwI-MR to Predict Chemotherapy Response of Liver Metastases and Hepatocarcinoma
      Conditions: Liver Metastases; Hepatocarcinoma
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations